Idera Pharmaceuticals, Inc. IDRAW Company Overview  Stock

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Idera Pharmaceuticals, Inc. IDRAW Company Overview 

Stock Message Board http://investorshangout.com/search?q=IDRAW&am...mp;yt1=Go!

Idera Pharmaceuticals, Inc. IDRAW Current Price and Quotes
1.77
Previous Close
1.77
Open
N/A

Daily Range
N/A - N/A
52wk Range
1.77 - 0.83

Volume
0
Dividend
N/A

Average Vol (3m)
447,033
Yield
N/A

Idera Pharmaceuticals, Inc. IDRAW
Company Information
345 Vassar Street
Cambridge, MA 02139

Website: http://www.iderapharma.com
Phone: (617) 679-5500

Idera Pharmaceuticals, Inc. IDRAW
Not Available

Idera Pharmaceuticals, Inc. IDRAW
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Latest Report Jun 30, 2013 10-Q
CIK 0000861838
Fiscal Year End 12/31
OTC Marketplace Grey Market
Profile Data
SIC - Industry Classification 2836 - Biological products, except diagnostic
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Sudhir Agrawal CEO
Louis Arcudi CFO
Company Directors
Not Available
Company Notes
Formerly=Hybridon, Inc. until 9-05
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Idera Pharmaceuticals, Inc. IDRAW
IDRAW Security Details Other Company Securities
Share Structure
Market Value1 Not Available
Shares Outstanding Not Available
Float Not Available
Authorized Shares Not Available
Par Value  Not Available
Shareholders
Shareholders of Record Not Available
Short Selling Data
Short Interest 250,000 (100%)
Aug 15, 2013
Significant Failures to Deliver  No
Transfer Agent(s)


Idera Pharmaceuticals, Inc. IDRAW Recent News


Aug 29, 2013 Idera Pharmaceuticals Enters into Agreement with NCI to Evaluate Use of TLR Antagonists for the Treatment of Genetically Defined Lymphomas
Aug 15, 2013 Idera Pharmaceuticals Reports Second Quarter 2013 Financial Results and Corporate Highlights
Jul 29, 2013 Dr Stock Pick Mid Day Alert
Jul 18, 2013 Idera Announces Issuance of US Patent Covering IMO-8400, Lead Candidate in Phase 2 Trial
Jul 10, 2013 Idera Pharmaceuticals Appoints James Geraghty as Chairman of the Board of Directors
Jul 1, 2013 Idera Pharmaceuticals Announces Results of Phase 1 Clinical Trial of IMO-8400, Toll-like Receptor Antagonist Drug Candidate for Autoimmune and Inflammatory Diseases
Jun 21, 2013 Idera Pharmaceuticals to Present Positive Phase 1 Trial Results on TLR Antagonist IMO-8400 for the Treatment of Autoimmune Diseases at FOCIS 2013
Jun 5, 2013 Idera Pharmaceuticals Announces Initiation of a Phase 2 Trial of IMO-8400 in Patients with Moderate to Severe Plaque Psoriasis


Idera Pharmaceuticals, Inc. IDRAW Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 51 53 16,110 34,518
Cost of Revenue - - - -
Gross Profit 51 53 16,110 34,518
Operating Expenses
Research and Development 13,673 17,969 24,226 18,570
Sales, General and Admin. 6,279 7,939 9,867 8,561
Non-Recurring Items - - - -
Other - - - -
Operating Income (19,901) (25,855) (17,983) 7,387
Income From Continuing Operations
Add'l Income/Expense Items 661 2,079 22 118
Earnings Before Interest and Tax (19,240) (23,776) (17,961) 7,505
Interest Expense - - 2 3
Earnings Before Tax (19,240) (23,776) (17,963) 7,502
Income Tax - - - (44)
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (19,240) (23,776) (17,963) 7,546
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (19,240) (23,776) (17,963) 7,546
Preferred Stock and Other Adjustments (3,210) (4,548) - -
Net Income Applicable to Common Shareholders (22,450) (28,324) (17,963) 7,546

IDRAW Idera Pharmaceuticals, Inc. Research DD Guide

IDRAW Idera Pharmaceuticals, Inc. Stock Message Board http://investorshangout.com/search?q=IDRAW&am...mp;yt0=Go!
IDRAW Idera Pharmaceuticals, Inc. Stock Quote http://www.otcmarkets.com/stock/IDRAW/quote
IDRAW Idera Pharmaceuticals, Inc. Stock Chart http://www.otcmarkets.com/stock/IDRAW/chart
IDRAW Idera Pharmaceuticals, Inc. Company Info http://www.otcmarkets.com/stock/IDRAW/company-info
IDRAW Idera Pharmaceuticals, Inc. Recent News http://www.otcmarkets.com/stock/IDRAW/news
IDRAW Idera Pharmaceuticals, Inc. Financials http://www.otcmarkets.com/stock/IDRAW/financials
IDRAW Idera Pharmaceuticals, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/IDRAW/filings
IDRAW Idera Pharmaceuticals, Inc. Short Sales http://www.otcmarkets.com/stock/IDRAW/short-sales
IDRAW Idera Pharmaceuticals, Inc. Insider Disclosure http://www.otcmarkets.com/stock/IDRAW/insider-transactions
IDRAW Idera Pharmaceuticals, Inc. Research Reports http://www.otcmarkets.com/stock/IDRAW/research
IDRAW Idera Pharmaceuticals, Inc. Summary http://finance.yahoo.com/q?s=IDRAW
IDRAW Idera Pharmaceuticals, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=IDRAW+Historical+Prices
IDRAW Idera Pharmaceuticals, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=IDRAW
IDRAW Idera Pharmaceuticals, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=IDRAW+Basic+Chart
IDRAW Idera Pharmaceuticals, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=IDRAW+Basic+Tech.+Analysis
IDRAW Idera Pharmaceuticals, Inc. Headlines http://finance.yahoo.com/q/h?s=IDRAW+Headlines
IDRAW Idera Pharmaceuticals, Inc. Press Releases http://finance.yahoo.com/q/p?s=IDRAW+Press+Releases
IDRAW Idera Pharmaceuticals, Inc. Company Profile http://finance.yahoo.com/q/pr?s=IDRAW+Profile
IDRAW Idera Pharmaceuticals, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=IDRAW+Key+Statistics
IDRAW Idera Pharmaceuticals, Inc. Industry http://finance.yahoo.com/q/in?s=IDRAW+Industry
IDRAW Idera Pharmaceuticals, Inc. Major Holders http://finance.yahoo.com/q/mh?s=IDRAW+Major+Holders
IDRAW Idera Pharmaceuticals, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=IDRAW+Insider+Transactions
IDRAW Idera Pharmaceuticals, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=IDRAW+Insider+Roster
IDRAW Idera Pharmaceuticals, Inc. Income Statement http://finance.yahoo.com/q/is?s=IDRAW
IDRAW Idera Pharmaceuticals, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=IDRAW
IDRAW Idera Pharmaceuticals, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=IDRAW+Cash+Flow&annual
IDRAW Idera Pharmaceuticals, Inc. Nasdaq http://www.nasdaq.com/symbol/IDRAW
IDRAW Idera Pharmaceuticals, Inc. Market Watch http://www.marketwatch.com/investing/stock/IDRAW
IDRAW Idera Pharmaceuticals, Inc. Bloomberg http://www.bloomberg.com/quote/IDRAW:US
IDRAW Idera Pharmaceuticals, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=IDRAW
IDRAW Idera Pharmaceuticals, Inc. Bussinessweek http://investing.businessweek.com/research/st...cker=IDRAW
IDRAW Idera Pharmaceuticals, Inc. Barchart http://www.barchart.com/quotes/stocks/IDRAW
IDRAW Idera Pharmaceuticals, Inc. OTC Short Report http://otcshortreport.com/index.php?index=IDRAW
IDRAW Idera Pharmaceuticals, Inc. Investopedia http://www.investopedia.com/markets/stocks/IDRAW/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

U.S. Millionaire Surge: Market Waves or Mirage?

Updated Category News Views 11

Flashing Billions: Minting Millionaires at Breakneck Speed It sounds like something out of an 80s movie: every single day, over 1,200 folks in the United States become millionaires. Yep, you heard right. The UBS Global Wealth Report 2026 threw that number out, and it sure caught my attention. It's not everyday you hear about the U.S. cranking out millionaires like they're...

Continue Reading
Plata Hits $1 Billion ARR in Record Digital Bank Growth

Updated Category News Views 14

Plata Rocks the Boat with Rapid Revenue Growth When a digital bank like Plata rakes in $1 billion in Annual Recurring Revenue (ARR) within just 3.5 years, you can't just shrug it off. That's blazing fast by any standard, especially for a financial institution. Emerging from Mexico, this bank's rocket-like ascent is flinging the doors wide open for what's possible in the...

Continue Reading
Netcapital Faces Securities Fraud Claims: Key Investor Notes

Updated Category News Views 5

Netcapital Under Fire: The Suit Unfolds You ever see a stock go through such highs and lows that you wish you had popcorn on standby? Well, that's where Netcapital Inc. (NASDAQ: NCPL) is sitting right now, in the midst of a class action lawsuit that's got investors' heads spinning. The accusations are serious: false and misleading statements about revenues that seem to...

Continue Reading
Cruise Planners Sets AI Benchmark in Travel Innovs

Updated Category News Views 10

Unveiling the AI Arsenal of Cruise Planners Alright, listen up, folks. When you think about travel and tech, Cruise Planners ain't just dipping a toe—they're cannonballing right in, splashing everyone around with their shiny new AI tricks. Twenty-three. That's how many innovations they're flaunting this year. It's like they're running a tech marathon, and boy, are they...

Continue Reading
Taiwan Excellence Sparks Smart Automotive Innovation at SEMA

Updated Category News Views 7

Taiwan's making waves, folks, and it's not your everyday splash in the automotive pool. At SEMA 2026, Taiwan Excellence Pavilion is the place to be with its array of intelligent automotive solutions. This ain't just your run-of-the-mill car show gimmickry—it's the future rolling in real-time. Driving Innovation: From Components to Smart Systems The name of the game is...

Continue Reading
Art Print Paper: Finding the Perfect Match for Masterpieces

Updated Category News Views 14

You ever stand in a gallery and notice how some art just lights up the room while others barely get a second glance? Well, a lot of that magic starts with an unsung hero—paper choice. I came across this bit from HelloNation diving into what makes paper selection a cornerstone for fine art prints. Now, I ain't an artist, but even a bruiser trader like me can see the...

Continue Reading
Noé Hinojosa Jr. Honored for Leadership in Business

Updated Category News Views 8

From Bonds to Ballgames: Hinojosa's Impact Listen up, because this one’s more than just another accolade on a shelf. Noé Hinojosa Jr., a big gun over at TRB Securities, is getting the 2026 Hispanic Business Salute Award, and it's a doozy. Awarded by all the big wigs—UPS, NBC 5, Telemundo 39, and the Dallas Cowboys—this isn't a small pat on the back. It's a full-on...

Continue Reading
Decoding Love: The Real Patterns of Relationships

Updated Category News Views 7

The Relationship Maze: More Than Meets the Eye Love ain't just a simple spark over a fancy dinner, let me tell you. In Dr. Bernadette Marson’s ‘The Relationship Code,’ she digs into seventy-seven elements gnawing at why relationships can crumble or thrive. It’s like a blueprint of human entanglements—a veritable explorer’s guide to the vast, wild creation we...

Continue Reading
2GenPen & LordCap Team Up: Game-Changer in ABS?

Updated Category News Views 9

New Kids on the Structured Credit Block? Well, it looks like we're in for a ride with 2GenPen teaming up with Lord Capital to shake up the asset-backed securities (ABS) world. They're strutting their stuff by launching a strategic collaboration to boost credit analysis. Think of it as a power-up for ABS transactions—because nobody loves a murky credit rating. The Heart...

Continue Reading
Richard Huffman Joins IFA Board, Strengthens Franchise Ties

Updated Category News Views 17

Ever wonder how the cogs in this massive machine called franchising keep turning? It's folks like Richard Huffman who step up to the plate, and his recent election to the International Franchise Association (IFA) Board of Directors is worth a second glance. Huffman: A Franchise Veteran Now, Huffman isn't some rookie in the world of franchising. You see, back in '94, he...

Continue Reading

Top 5 Most Recently Viewed Articles

Projected Growth of Asphalt Additives: A $6.60 Billion Opportunity

Updated Category News Views 119

The Growing Asphalt Additive Market The asphalt additive market is on track for significant growth, with projections estimating its value will rise from USD 4.62 billion to USD 6.60 billion by 2030. This notable increase comes with a compound annual growth rate (CAGR) of 7.4%, driven largely by increased investment in infrastructure development. As governments and private...

Continue Reading
Amazing Wealth Growth from Chemed Stock Over Two Decades

Updated Category News Views 87

Investing in Chemed: A 20-Year Journey Chemed Corporation (NYSE: CHE) has demonstrated an impressive ability to outperform the market consistently over the past 20 years. By achieving an average annual return of 16.29%, it has outstripped the broader market by 7.74%. As of now, Chemed's market capitalization stands at an impressive $9.15 billion, reflecting its strong...

Continue Reading
Elevating Patient Experience: Jared Allen Joins SONIFI Health

Updated Category News Views 216

Introducing Jared Allen: New Leadership at SONIFI Health Leading the charge in patient engagement technology, SONIFI Health is thrilled to announce the addition of Jared Allen as the new senior vice president of healthcare sales. With a robust background in technology and healthcare, Allen brings over 20 years of experience, ensuring that SONIFI Health continues to excel...

Continue Reading
Calamos Investments Funds Declaration of Monthly Distributions

Updated Category News Views 112

Understanding Calamos Investments Monthly Distributions Calamos Investments has recently shared important updates regarding the monthly distributions for its closed-end funds. These distributions are crucial for shareholders as they represent an ongoing return on investment. Understanding these distributions and their sources can help investors make informed decisions...

Continue Reading
Transforming Healthcare in Xinjiang Through Paired Assistance

Updated Category News Views 98

Transformative Healthcare Initiatives in Xinjiang Recently, significant strides have been made in healthcare accessibility in regions like Xinjiang, a process greatly aided by the paired assistance program. This initiative has fostered collaboration between local healthcare providers and specialists from more developed areas, enhancing the quality of care for local...

Continue Reading